Searched for
SEQUENT SCIENTIFIC MERGER
Boehringer Ingelheim, Viyash Scientific enter pet healthcare pact in IndiaGerman biopharma giant Boehringer Ingelheim is partnering with Viyash Scientific to bring its pet healthcare products to India. This collab...- Sequent-Viyash may soon have zero debt: Viyash founder and combined co's CEO-designate Hari Babu Bodepudi to inject ₹400 croreHari Babu Bodepudi is making a significant capital infusion into the newly merged Sequent Scientific and Viyash Life Sciences. This strateg...
- Stocks in news: Groww, HUL, Infosys, Sequent Scientific, TCS, Azad EngineeringIndian markets experienced a volatile trading session on weekly expiry day, declining by nearly half a percent. This extends the current co...
- NCLT clears Sequent Scientific–Viyash Life Sciences merger worth ₹8,000 croreCarlyle's portfolio companies, Sequent Scientific and Viyash Life Sciences, have received National Company Law Tribunal approval for their ...
- Sequent and Viyash Life merger plan gets shareholder approvalThe proposed merger of Sequent Scientific and Viyash Life Sciences, backed by Carlyle, has received overwhelming shareholder support. This ...
- Carlyle portfolio firms SeQuent Scientific and Viyash Life get stock exchange nod for mergerCarlyle-backed SeQuent Scientific and Viyash Life Sciences have secured stock exchange approvals for their merger. Next, they will approach...
- CCI clears merger of nine pharma entities with Sequent ScientificThe Competition Commission of India has approved the amalgamation of nine entities into Sequent Scientific Ltd (SSL), enhancing its positio...
- Sequent to absorb Viyash, giving 56 for 100 sharesIn a stock exchange filing, Sequent Scientific said its board has approved a proposal to merge Viyash Life Sciences and its group companies...
- Bulls take a breather, financials drag Sensex 264 points lower, Nifty slips below 26,200Sensex and Nifty ended their streak of record highs, closing in the red due to declines in heavyweight financial stocks. Sensex fell by 264...
- Sequent Scientific shares soar 18% on Rs 8,000 crore merger with Viyash Life SciencesSequent Scientific and Viyash Life Sciences have announced a merger that will result in the two companies forming a combination that will c...
- Sequent Scientific, Viyash Life Sciences announce Rs 8,000 crore mergerSequent Scientific and Viyash Life Sciences have announced a merger, creating a platform with leadership in animal pharmaceuticals and inte...
- Carlyle Group portfolio companies in advanced talks for a potential mergerSequent Scientific, which is in animal health business, posted revenue of around Rs 1,400 crore in FY24. It had earnings before interest, t...
- Sequent Scientific, Viyash Life Sciences explore merger worth Rs 7000-8000 crSequent Scientific and Viyash Life Sciences are discussing a potential merger valued at Rs. 7000-8000 crore. Both companies' boards will me...
- Sensex back in red after a day of hiatus; Paytm spikes 17%While about 6 per cent fall from the peak in Nifty has made the market healthy, the valuations continue to be high. Therefore, FIIs may con...
- After rallying 6 times in 3 years, this API maker just got first ‘sell’ ratingThe stock, which got listed at Rs 288 on June 27, 2018, hit a record high of Rs 1,859 on Wednesday, rising a solid 550 per cent, or 6.45 ti...
- Talking Stock: Hold KRBL, L&T; add HDFC Bank, Nestle IndiaSequent Scientific trades at a fair valuation of around 21 PE on one-year forward earnings.
- Animal healthcare yields rich dividends for SequentMargins should continue expanding with higher penetration in the more regulated markets.
- Lyka board to consider merger of two subsidiaries with itselfDrug firm Lyka Labs today said its board of directors will meet next week to consider the merger of the company's subsidiaries Lyka Healthc...
- Sequent Unit set to buy Mumbai-based Lyka's veterinary businessAlivira Animal Health, a joint venture of Sequent Scientific and Shasun Pharmaceuticals, is set to buy the veterinary business of Mumbai-ba...
- Pharma in 2014: Deals worth billions and fines worth millionsRanbaxy, founded by the family of Malvinder and Shivinder Mohan Singh, was at the centre of most of the developments for major part of the ...
Load More
